GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eupraxia Pharmaceuticals Inc (TSX:EPRX) » Definitions » Net Interest Income (for Banks)

Eupraxia Pharmaceuticals (TSX:EPRX) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Eupraxia Pharmaceuticals Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Eupraxia Pharmaceuticals (TSX:EPRX) Business Description

Traded in Other Exchanges
Address
201-2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms.
Executives
James Allen Helliwell Director